C275 Orion JPG highres

Sensitive and rapid molecular detection of Campylobacter

Orion GenRead Campylobacter is a new molecular test intended for detection of Campylobacter species C. jejuni, C. coli and C.lari in patients suspected of having Campylobacter infection. The ready-to-use test kit is used together with the small Orion GenRead Instrument and is suitable for laboratories of various settings and sizes. Performing thetest requires neither special facilities nor expertise in molecular methods. An internal control is integrated into each test tube to contol for the reaction and ensure reliable results. The test, done directly from feces, has a simple sample handling procedure without a separate DNA purification step. The molecular test offers improved sensitivity over culture and allows detection also of nonculturable isolates. Results are provided in less than one hour which enables prompt diagnosis and treatment of compromised patients. The Orion GenRead system is based on SIBA technology, Orion Diagnostica’s proprietary isothermal nucleic acid amplification technique.

Read more

C276 Reagena

Rapid test for determination of chemokine CXCL13

Chemokine CXCL13 is considered as a relevant biomarker of acute Lyme neuroborreliosis (LNB). Until recently, the laboratory diagnosis of LNB was based on cerebrospinal fluid (CSF) pleocytosis and the presence of intrathecal Borrelia specific antibodies. As shown in several studies, CXCL13 concentration is significantly elevated in CSF of LNB patients even before intrathecal production of Borrelia specific antibodies. Furthermore, CXCL13 rapidly decreases in CSF as a result of effective antibiotic therapy.  Reagena has developed a lateral flow rapid test, ReaScan CXCL13, for the detection of CXCL13 in human CSF. The ReaScan CXCL13 test procedure takes only 20 minutes and the intensity of the test line is read with the handheld ReaScan rapid test reader giving a numerical and objective result. ReaScan CXCL13 provides a new diagnostic tool for the rapid determination of CXCL13 near the patient and helps clinicians in the treatment decision for suspected LNB patients.

Read more

C272 Randox crop

Upgraded online QC software

Following the successful launch of version 1.6, including new features like the automatic calculation of Sigma Metrics and Measurement Uncertainty, Randox Quality Control are announcing the launch of Acusera 24.7 Live Online Version 2.0.  Following extensive development based on customer feedback, Acusera 24.7 Live Online 2.0 is faster, with a simplified user interface and an enhanced user experience. In addition to the range of features offered in earlier versions, including QC multi-rules, interactive charts and the unique dashboard interface, the following new features have been added to the Acusera 24.7 Live Online software to speed up the review process and provide at-a-glance performance assessment:  
Peer data is updated instantly allowing real-time peer comparison, faster troubleshooting and identification of trends. Levey-Jennings charts now have even more functionality with the ability to add events such as calibration and reagent lot changes for advanced review of trends. The new user interface is faster and easier to use, enhancing user experience. Bi-directional communication with LIMS, new to Acusera 24.7 Connect, is now possible.  A new histogram chart provides a quick visualization of any test system bias.  Acusera 24.7 Connect and EDI is 100 times faster at importing QC results to the software, increasing efficiency in the lab. A new Exception Report provides a count of the number of results for a given time period that exceed 2SD, allowing corrective action to be taken.  Support for multiple devices based on responsive design that will scale to fit any platform including mobile, tablet and PC is also featured. Users can create a custom configuration that can be shared across other instruments in their lab and also other labs in their group, speeding up the configuration process for lab chains.  Performance limits, QC multi-rules and peer groups may now be customized depending on user preferences for each different analyte, instrument or lot of control. 

Read more

C277 Fujirebio

Fully automated assay aiding in the early diagnosis of neurodegeneration

Fujirebio Europe recently launched the Lumipulse G ß-Amyloid 1-42 assay for its fully automated LUMIPULSE immunoassay systems. This CE-marked CLEIA (chemiluminescent enzyme immunoassay) kit allows the quantitative measurement of ß-amyloid in human cerebrospinal fluid within just 30 minutes. The Lumipulse G ß-Amyloid 1-42 assay is based upon Fujirebio’s well established, pioneering ELISA-based INNOTEST assay (the first neurodegeneration testing kit launched in 1995) and the know-how of Fujirebio in robust and automated CLEIA testing since the first LUMIPULSE instrument was released in 1992. The Lumipulse G ß-Amyloid 1-42 assay is the first fully automated testing solution for early detection of Alzheimer’s disease. It gives clinical laboratories access to more precise and reliable neurodegeneration testing and, of course, significantly faster results. Alzheimer’s disease starts silently, and develops several years before clinical symptoms appear. Until recently, it has been difficult for physicians to predict which individuals with memory problems will eventually develop AD, and which ones will not. New diagnostic tools to help detect AD as early as possible, and make early diagnosis with the highest level of certainty are of fundamental importance for both physicians and the patients and families involved. This is because memory complaints can result from several causes and may be reversible. Another reason that early detection tools are urgently needed is because it is believed that the treatment of diseases such as AD ideally should begin as soon as possible. Pharmaceutical companies trying to develop new AD treatments need reliable tests to establish clear-cut treatment groups, and means of monitoring the effectiveness of candidate treatments. 

Read more

West Medica

Automatic analysis of bone marrow cells

Vision Hema® Bone Marrow is the first system worldwide for automatic analysis of bone marrow cells. The system automatically scans slides, identifies and pre-classifies bone marrow cells. After that the specialist validates the results using a PC.  
The main characteristics of the system are:  automatic scanning of slides; automatic identification and pre-classification of bone marrow cells: Blasts, Basophils, Eosinophils, Promyelocytes, Myelocytes, Metamyelocytes, Band neutrophils, Segmented neutrophils, Lymphocytes, Erythroblasts and others; bone marrow examination, marking of areas showing pathology, database for archive management; remote access and network capabilities; bi-directional communication with LIS. 
Vision Hema® Bone Marrow automates the analysis of bone marrow cells. 
For more information please visit our web-site bm.wm-vision.com

Read more

C279 Euroimmun crop

Full automation of ELISA

The new EUROLabWorkstation ELISA provides complete walkaway processing of ELISA, from primary sample to end result. The high-throughput system has a high capacity of up to 15 microplates and more than 700 samples in one run. More than 200 tests can be processed per hour. Samples and reagents are pipetted at high speed using 10 pipetting channels, and the microplates are processed with high efficiency. Soft wareguided loading and barcode/matrixcode scanning of samples, reagents and accessories ensure high result integrity and minimal hands-on time. Moreover, the automated identification of samples, plates, slides and reagents throughout the entire process enables comprehensive traceability. Personnel expenditure is minimized by the handling of plates or slides by the integrated robot. The dynamic working area of the EUROLab- Workstation ELISA allows laboratory workflow to be adapted to individual requirements. The system has a deck capacity of 45 tracks and a variable configuration with a definable number of needles and selectable additional modules. EUROIMMUN offers an extensive portfolio of ELISA which are validated for use on the instrument. The parameter spectrum encompasses over 350 parameters for autoimmune and infection diagnostics. Starting sample materials include serum, plasma and cerebrospinal fluid. All EUROIMMUN ELISA come complete with colour-coded, ready-to-use reagents for added convenience and standardization.
Read more

C284 Thermo Fisher crop

Automating blood cell washing applications

A new automated, high-performance cell washer has been specifically designed to enable precise, thorough, reproducible and rapid blood cell washing of up to 24 tubes in a three-minute run. Fully automated, the Thermo Scientific CW3 Cell Washer has been uniquely engineered to combine the benefits of efficient performance with user-friendly design and safe operation. Users can select one of the pre-set programs that have been designed to run in automatic mode, accelerate blood cell washing cycles and achieve significant time savings, while allowing for maximum ease of use and sample safety. Effective blood cell washing is extremely important in the removal of plasma and unwanted antibodies to ensure that patients will not be affected by adverse health effects and that blood-transfused products will retain all of their beneficial attributes. The CW3 Cell Washer has been designed to achieve optimal corpuscle dryness by allowing users to pre-set the desired decanting speed. At the same time, corpuscle washing is improved via the optional overfl ow method. For washing, tubes swing at a fixed positive angle to sediment cells rapidly at the bottom of the tube, whereas when decanting, the rotor holds tubes at a slightly negative angle and the saline is decanted centrifugally. The result is optimized pelleting performance. Furthermore, the flexibility to use 12- or 24-place rotors and standardized, repeatable procedures enables the instrument to adapt to the processes and protocols already in place within the lab. Built with sample safety in mind, the compact CW3 Cell Washer features an automatic alert mechanism that informs users about low or disrupted saline levels and when a run is complete. A view port on top of the unit facilitates quick calibration, while the saline distributor is mounted directly on top of the rotor to reduce the risk of cross-contamination. The new washer is also equipped with tube racks bearing red and blue number labelling for easy sample balancing. In addition, when closed-monitoring of the washing process is required, the system can be operated manually to allow for cells that need to be washed step-by-step. As a low maintenance instrument, the CW3 Cell Washer includes easy-to-change pump tubing and an easy-toremove catch basin, rotor and rotating bowl.
Read more

C288 Biomerieux crop

Advanced panel for respiratory tract infection testing

The newly CE marked FilmArray Respiratory Panel 2 plus (RP2plus) tests for 22 pathogens (18 viruses and 4 bacteria) responsible for respiratory tract infections. It advances the existing FilmArray Respiratory Panel (RP) by reducing the assay time from about an hour to less than 45 minutes, improving overall sensitivity, and updating several assays. FilmArray RP2plus also includes 2 additional pathogens: Bordetella parapertussis, one of the causative agents of pertussis or whooping cough, a highly infectious bacterial disease, and Middle East Respiratory Syndrome coronavirus (MERS-CoV). According to the WHO, the recent MERS-CoV outbreak in the Republic of Korea demonstrated a great potential for widespread transmission and severe disruption both to the health system and to society. The MERS-CoV case fatality rate is approximately 36%. Bordetella parapertussis infections represent a significant cause of whooping cough which is oft en missed because of a clinical presentation largely indistinguishable from other viral infections and of lack of reliable diagnostic tests. The FilmArray RP2plus is available for use on the FilmArray 2.0 and FilmArray Torch systems and will be commercially available in the countries that recognize CE marking by mid-June 2017.
Read more

C287 Siemens missing pic page33

High-sensitivity Troponin I IVD assay

The new high-sensitivity troponin I (TNIH) in vitro diagnostics assay is designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma. High-sensitivity troponin plays a critical role in the timely diagnosis of AMI, or heart attacks. The presence of cardiac troponin is specific to heart muscle death. The detection of circulating troponins has long been recognized as the gold standard for the diagnosis of AMI in patients who present with chest pain in the emergency room. Compared to traditional troponin assays, the Siemens Healthineers TNIH assay is able to detect lower levels of troponin and smaller changes to a patient’s troponin levels, which may be an early indication of AMI. This design affords clinicians greater confidence in patient results at the low end of the assay range by delivering precision that provides the ability to measure slight, yet critical, changes between serial troponin I values. Precision at the low end is important to minimize analytic variation that could confuse a clinician’s assessment of a clinically significant change. With this data in hand, clinicians have the ability to more quickly diagnose and treat patients with suspected AMI, in some cases in as little as one to three hours. The TNIH assay meets current European Society of Cardiology guideline recommendations. Further, clinical study data involving approximately 2,500 patients at different time points from more than 30 trial sites in the United States and Europe demonstrate the TNIH assay’s efficiency. The TNIH assay is available for use on the ADVIA Centaur XPT and ADVIA Centaur XP systems, the company’s high efficiency laboratory analysers. The company also plans to make the high-sensitivity troponin I assays available on its other testing systems, including the Dimension Vista, Dimension EXL and Atellica IM analyser.
Read more

C281 Beckman

Chemistry analyser

The new DxC 700 AU chemistry analyser brings together the advanced capabilities of two successful Beckman Coulter products – the simple intuitive design of the DxC analyser and the robust throughput and workhorse capabilities of the AU analyser – into one standardized platform designed to meet the needs of mid- to high-volume clinical laboratories. Additionally, by gaining further input from the clinical laboratory professionals, who are under pressure daily to produce faster results and manage resources more efficiently, additional features and benefits were identified and designed into the product. The DxC 700 AU chemistry analyser reduces the number of test-processing steps by 30%, streamlining workflow for laboratory professionals. The reduction in steps is the result of powerful operating software, an all-new design and an intuitive user-interface that allow operators to spend less time on daily tasks and more time producing the quality results that empower better decision-making for better patient care. The new software is easy to learn and simple to operate with very little experience. The ability to load reagents ‘on-the-fly,’ while the instrument is running, saves time and minimizes disruption to workflow. Along with its efficiency, the DxC 700 AU analyser reduces total cost of ownership by using fewer consumables compared to other industry same-class systems. Additionally, the system uses concentrated reagents, longlasting ion-selective electrodes (ISEs), and non-disposable cuvettes to help laboratory specialists achieve financial goals and manage resources. The system is further designed for time- and cost-savings superior uptime through the Beckman Coulter “3 & 60” concept. The “3 & 60” concept gives laboratory staff the ability to change out replacement parts in three steps, within 60 seconds, with no tools. The DxC 700 AU analyser is part of Beckman Coulter’s Total Laboratory Solution, featuring a broader comprehensive portfolio that provides the flexibility to tailor systems based on a laboratory’s volume and space needs. Customers have access to an array of efficient solutions, including: the Power Link system, which connects small-footprint automation with chemistry and immunoassay analysers; the Power Express, a multi-discipline, tracked-based automation solution; and, Remisol or Command Central, both of which offer robust information data management capabilities. The DxC 700 AU system is currently available in the U.S. and will become available in other regions throughout the world in 2017.
Read more